Economic Burden of Generalized Pustular Psoriasis in Sweden: A Population-Based Register Study.
Sofia LöfvendahlJenny M NorlinMarcus Schmitt-EgenolfPublished in: Psoriasis (Auckland, N.Z.) (2022)
This study demonstrates a higher economic burden for GPP patients compared to both the general population and patients with PV, with inpatient visits and use of biologic drugs as major cost driving factors. Only fractions of the costs for physician visits and inpatient stays were attributable to specific GPP problems, indicating a higher economic burden of GPP-consequences and complications.